









Markets
/
Stocks
/
nasdaq-trib
/

Trinity Biotech PLC

TRIB

1.190USD

-0.020-1.65%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

9.87MMarket Cap

LossP/E TTM



Trinity Biotech PLC

1.190

-0.020-1.65%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

144 / 207

Overall Ranking

417 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The Company sells its products direct in the United States and through a network of international distributors.

Growing

The company is in a growing phase, with the latest annual income totaling USD 61.55M.

Undervalued

The company’s latest PE is -0.23, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 3.17M shares, decreasing 39.08% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 11.39K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 8.62.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.14, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 15.15M, representing a year-over-year increase of 3.24%, while its net profit experienced a year-over-year increase of 29.19%.

Score

Industry at a Glance

Previous score

6.14

Change



Financials

3.55

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.92

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

6.02

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.15

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -0.24, which is -37.18% below the recent high of -0.15 and 6.15% above the recent low of -0.22.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 144/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.70.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 6.24, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.62 and the support level at 0.94, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.24

Change

-0.12

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.053

Neutral

RSI(14)

48.705

Neutral

STOCH(KDJ)(9,3,3)

55.803

Neutral

ATR(14)

0.086

Low Volatility

CCI(14)

-15.390

Neutral

Williams %R

73.810

Sell

TRIX(12,20)

-0.204

Sell

StochRSI(14)

32.555

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

1.194

Sell

MA10

1.174

Buy

MA20

1.293

Sell

MA50

1.087

Buy

MA100

0.899

Buy

MA200

0.835

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 16.99%, representing a quarter-over-quarter increase of 1.23%. The largest institutional shareholder is James Simons, holding a total of 11.39K shares, representing 0.31% of shares outstanding, with 70.96% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

MiCo IVD Holdings, LLC

2.24M

Hunter Associates Investment Management LLC

375.11K

-0.92%

Whitefort Capital Management, LP

81.90K

Renaissance Technologies LLC

Star Investors

76.67K

-59.45%

Highbridge Capital Management, LLC

33.75K

Moss Adams Wealth Advisors LLC

25.67K

Raymond James & Associates, Inc.

25.35K

Cambridge Investment Research Advisors, Inc.

22.28K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.05, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.